Changeflow GovPing

What do you monitor?

Curated feeds for your role. Pick your area and get exactly the sources you need.

Recent changes

Favicon for changeflow.com

Patent Application for Hot Air Curing Adhesive Method

The USPTO has published a patent application (US20260083921A1) for a method of curing adhesive with hot air treatment during the assembly of glass syringes. The application, filed by ATS Corporation, details a process involving dispensing, arranging, radiation curing, and hot air heating steps.

Routine Notice Healthcare
Favicon for changeflow.com

USPTO Patent Application for Atomizing Body Assembly

The USPTO has published a patent application (US20260083922A1) for an atomizing body assembly and soft mist device with improved sealing performance. The application details an assembly including a T-shaped steel member, chip-mounting part, filter cartridge, and O-ring designed to enhance sealing. The filing date was October 31, 2022.

Routine Notice Medical Devices
Favicon for changeflow.com

Capsule Inhaler for Phosphodiesterase-4 Inhibitor Patent Application

The USPTO has published a patent application (US20260083924A1) for a capsule inhaler device designed for administering a phosphodiesterase-4 inhibitor. The application, filed by Chiesi Farmaceutici S.P.A., details a drug product comprising a single-dose dry powder inhalation device and a pharmaceutical composition for treating respiratory diseases.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Patent Application for Variable Orifice Flow Shunt Devices

The USPTO has published a patent application (US20260083945A1) for variable orifice flow shunt devices designed to reduce peak systolic pressure. The application details devices with check valves and adjustable orifices for percutaneous shunting from the superior vena cava to the right pulmonary artery.

Routine Notice Healthcare
Favicon for changeflow.com

Patent Application for Implantable Sensors and Shunting Systems

The USPTO has published a new patent application (US20260083946A1) for implantable sensors and shunting systems. The application details a system for shunting blood between heart atria and includes a sensor with an actuation element to reduce tissue ingrowth. The filing date was December 3, 2025.

Routine Notice Healthcare
Favicon for changeflow.com

Capsule Inhaler Patent for Phosphodiesterase-4 Inhibitor

The USPTO has published a new patent application (US20260083711A1) for a capsule inhaler designed for administering phosphodiesterase-4 inhibitors. The patent, assigned to Chiesi Farmaceutici S.p.A., details a drug product comprising a single-dose dry powder inhalation device and a pharmaceutical composition for treating respiratory diseases.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

USPTO Patent Application for Electrospraying Applicator Cartridges

The USPTO has published a new patent application (US20260084167A1) filed by Octet Medical, Inc. The application details disposable cartridges for electrospraying applicators, systems, and methods thereof. This represents a new intellectual property filing in the medical device sector.

Routine Notice Medical Devices
Favicon for changeflow.com

Powder Sprayer Patent Application

The USPTO has published a patent application (US20260084168A1) for a powder sprayer. The application details a device with specific air and powder inlets, a confluence channel, and an on-off valve system. The filing date was February 24, 2022.

Routine Notice Medical Devices
Favicon for changeflow.com

Medical System and Liquid Circulation System for Brain Treatment

The USPTO has published a patent application (US20260083947A1) for a medical system and liquid circulation system designed for brain treatment. The system aims to efficiently deliver liquid to the brain while managing intracranial pressure fluctuations by controlling injection and discharge periods.

Routine Notice Healthcare
Favicon for changeflow.com

Patent Application for Microstructure Array Delivering Active Agents

The USPTO has published a patent application (US20260083948A1) for a microstructure array designed for delivering active agents through the skin. The application details a formulation comprising dissolving microstructures attached to a base, intended for transdermal drug delivery.

Routine Notice Pharmaceuticals

Showing 3301–3310 of 30,562 changes

1 329 330 331 332 333 3057

Get alerts when regulations change

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.